A Phase I/II trial of Anti-CEA DNA vaccine (ACVA) with a CEA/pDom fusion gene given by intramuscular injection in patients with carcinomas expressing CEA.
Phase of Trial: Phase I/II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Carcinoembryonic antigen DNA vaccine (Primary)
- Indications Cancer
- Focus Pharmacodynamics
- 01 Sep 2009 New trial record